About RegenLab
RegenLab is a company based in Brooklyn (United States) founded in 2003. RegenLab offers products and services including RegenKit® Wound Gel, RegenKit® BCT, RegenKit® THT®, and Regen® Spray Applicator. RegenLab operates in a competitive market with competitors including SetPoint Medical, Babson Diagnostics, Tasso, YourBio Health and Velano Vascular, among others.
- Headquarter Brooklyn, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website regenlabusa.com
- Social LinkedIn X Facebook Instagram
- Legal Name Regenlab Usa, Llc
- Latest Funding Round$5M (USD), Debt – Conventional
Jun 2025
Products & Services of RegenLab
RegenLab offers a comprehensive portfolio of products and services, including RegenKit® Wound Gel, RegenKit® BCT, RegenKit® THT®, and Regen® Spray Applicator.
Kit for wound healing using platelet-rich plasma.
Device for blood component therapy preparation.
System for advanced tissue healing applications.
Tool for applying cellular preparations.
Funding Insights of RegenLab
- Total Rounds 1
- Last Round Debt – Conventional — $5M
- First Round $5M
(Jun 2025)
All 1 funding rounds of RegenLab with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2025 | $5M | Debt – Conventional | – | – | – |
People of RegenLab
1 people are tracked at RegenLab (1 in leadership).
| Name | Role | Group |
|---|---|---|
Giuseppe Calloni | CEO | Leadership |
Complete people profiles for RegenLab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RegenLab
2 dated milestones of RegenLab across 22 years, from founding to its latest funding, stage changes and deals.
- Founded RegenLab is founded.
- Funding First funding round of $5.0M.
Competitors of RegenLab
RegenLab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SetPoint Medical, Babson Diagnostics, Tasso, YourBio Health and Velano Vascular, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| setpointmedical.com | 2006 | Santa Clarita, United States | $363.17M | 46 | Implantable neuromodulation devices are developed for inflammatory diseases. | |
| babsondx.com | 2017 | Austin, United States | $37.7M | 57 | Blood testing services are offered using finger-prick microsamples. | |
| tassoinc.com | 2014 | Seattle, United States | $123.22M | 1 | Blood collection devices for diagnostic applications are developed. | |
| yourbiohealth.com | 2007 | Medford, United States | $102.23M | 32 | Push-button blood collection devices are manufactured for medical use. | |
| velanovascular.com | 2012 | San Francisco, United States | $51.05M | 19 | Provider of a needle-free blood collection device | |
| boomerangmedical.com | 2021 | Mountain View, United States | $35M | – | Bioelectronic devices are developed for autoimmune disease treatment. | |
| weavrhealth.com | 2005 | Cambridge, United States | $18.63M | 30 | Manufactures high-quality blood collection devices for medical applications. | |
| hippo-dx.com | 2020 | Belgium | $4.67M | 6 | Developer of a medical device to provide an automated test that detects allergies | |
| impulsebiomed.com | 2018 | Cape Town, South Africa | – | – | A reloadable adrenaline auto-injector is developed for severe allergic reactions. |
Detailed competitors of RegenLab
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of RegenLab
The website of RegenLab (regenlabusa.com) receives about 2K visits a month.
- Monthly visits2K
▲ 11.5% vs previous month
Websites whose visitors overlap most with RegenLab. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| regenlab.com | 100% | 11K | #1,691,801 | View details | |
drfechner.com | drfechner.com | 76% | – | #3,496,782 | – |
eclipseaesthetics.com | eclipseaesthetics.com | 74% | – | – | – |
wembleyclinic.co.za | wembleyclinic.co.za | 74% | – | – | – |
drnacicelik.com | drnacicelik.com | 73% | – | #8,414,721 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for RegenLab
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Regenlab
Complete news archive for RegenLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to RegenLab
10 companies that operate in the same segment as RegenLab (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RegenLab
RegenLab was founded in 2003 and raised its 1st funding round 22 years after it was founded.
RegenLab is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
Giuseppe Calloni is the current CEO of RegenLab.
RegenLab was founded in 2003 and is based in Brooklyn, United States. Medical devices for developing cellular therapies are provided by the company, focusing on the healthcare sector. Operations involve processing patient blood through centrifugation to isolate platelets for hard and soft tissue repair. Key products include Regenkit A-PRP, Regenkit A-PRP plus, RegenKit ACP 3, RegenKit-ETM-3, RegenKit-THT-3, and related accessories.
RegenLab's top competitors include SetPoint Medical, Babson Diagnostics and YourBio Health.
RegenLab offers RegenKit® Wound Gel, RegenKit® BCT, RegenKit® THT®, and Regen® Spray Applicator.
RegenLab operates through Regenlab Usa, Llc.